A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/16 (2006.01) A61P 35/00 (2006.01) A61P 35/04 (2006.01)
Patent
CA 2610281
A therapeutic agent for cancer comprising, as an active ingredient, a substance capable of binding to HB-EGF to thereby inhibit the binding between HB-EGF and an EGF receptor (particularly CRM197), the cancer being selected from the group consisting of bladder cancer, colorectal cancer or disseminated peritoneal metastatic cancer from gastric cancer and pancreatic cancer.
L~invention concerne un agent thérapeutique contre le cancer qui comprend, en tant qu'ingrédient actif, une substance susceptible de se lier à l~HB-EGF pour inhiber de ce fait la liaison entre l~HB-EGF et un récepteur EGF (en particulier le CRM197), le cancer étant choisi dans un groupe comprenant le cancer de la vessie, le cancer colorectal ou le cancer métastatique péritonéal disséminé à partir d~un cancer gastrique et d~un cancer pancréatique.
Mekada Eisuke
Miyamoto Shingo
Kirby Eades Gale Baker
The Research Foundation For Microbial Diseases Of Osaka Universi
LandOfFree
Therapeutic agent for cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agent for cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2046061